MEDGENICS INC's ticker is MDGN and the CUSIP is 58436Q203. A total of 67 filers reported holding MEDGENICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $34,000 | -20.9% | 6,020 | -22.0% | 0.00% | -50.0% |
| Q2 2016 | $43,000 | -17.3% | 7,722 | -34.7% | 0.00% | 0.0% |
| Q1 2016 | $52,000 | -42.2% | 11,821 | -20.8% | 0.00% | -33.3% |
| Q4 2015 | $90,000 | -32.8% | 14,933 | -12.8% | 0.00% | -40.0% |
| Q3 2015 | $134,000 | +63.4% | 17,130 | +28.6% | 0.01% | +66.7% |
| Q2 2015 | $82,000 | – | 13,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,058,400 | $8,277,000 | 4.07% |
| Belmont Global Advisors, Inc. | 155,000 | $1,212,000 | 2.06% |
| Broadfin Capital, LLC | 1,545,306 | $12,084,000 | 0.67% |
| CARL DOMINO INC | 34,134 | $267,000 | 0.21% |
| QVT Financial LP | 267,608 | $2,093,000 | 0.07% |
| WHITE PINE CAPITAL LLC | 20,000 | $156,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 119,000 | $931,000 | 0.02% |
| HYMAN CHARLES D | 13,000 | $102,000 | 0.02% |
| Kavar Capital Partners, LLC | 1,500 | $11,000 | 0.01% |
| Brick & Kyle, Associates | 1,000 | $8,000 | 0.01% |